Operating Lease, Payments of Ensysce Biosciences, Inc. from 31 Dec 2021 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: Ensysce Biosciences, Inc. quarterly and annual Operating Lease, Payments in USD history and change rate from 31 Dec 2021 to 31 Mar 2025.
Ensysce Biosciences, Inc. Operating Lease, Payments for the quarter ending 31 Mar 2025 was $20,681, a 9% decline year-over-year.
Ensysce Biosciences, Inc. annual Operating Lease, Payments for 2024 was $29,545, a 5.5% decline from 2023.
Ensysce Biosciences, Inc. annual Operating Lease, Payments for 2023 was $31,249, a 14% increase from 2022.
Ensysce Biosciences, Inc. annual Operating Lease, Payments for 2022 was $27,316, a 9.8% increase from 2021.
Source SEC data: View on sec.gov

Operating Lease, Payments, Quarterly (USD)

Operating Lease, Payments, YoY Quarterly Change (%)

Operating Lease, Payments, Annual (USD)

Operating Lease, Payments, YoY Annual Change (%)

Ensysce Biosciences, Inc. Quarterly Operating Lease, Payments (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$20,681	-$2,046	-9%	01 Jan 2025	31 Mar 2025	10-Q	13 May 2025	2025	Q1
Q1 2024	$22,727	+$3,607	+19%	01 Jan 2024	31 Mar 2024	10-Q	13 May 2024	2024	Q1
Q1 2023	$19,120	+$1,404	+7.9%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q1 2022	$17,716			01 Jan 2022	31 Mar 2022	10-Q	12 May 2022	2022	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$29,545	-$1,704	-5.5%	01 Jan 2024	31 Dec 2024	10-K	10 Mar 2025	2024	FY
2023	$31,249	+$3,933	+14%	01 Jan 2023	31 Dec 2023	10-K	15 Mar 2024	2023	FY
2022	$27,316	+$2,442	+9.8%	01 Jan 2022	31 Dec 2022	10-K	30 Mar 2023	2022	FY
2021	$24,874			01 Jan 2021	31 Dec 2021	10-K	31 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.